Modular Stems Dual Tapered — 135–145 mm Cemented Femoral Implants

Modular Stems Dual Tapered Gen X Series Sterile Stainless Steel, SKUs PS-OP-5577 through PS-OP-5582, is a collarless femoral implant system manufactured from medical-grade stainless steel for cemented total hip arthroplasty. The three clinical configurations are model 174X-135-S measuring 135 mm long and 10 mm wide, model 174X-140-M at 140 mm by 11 mm, and model 174X-145-L at 145 mm by 12 mm. Its polished, double-tapered body is designed for placement within a prepared polymethylmethacrylate cement mantle rather than cortical press-fit fixation. The rectangular stem profile narrows toward the distal tip and permits controlled axial settling under physiological loading while converting forces into compression within the surrounding cement. These implants support femoral reconstruction during primary total hip replacement for advanced osteoarthritis, avascular necrosis, inflammatory arthropathy, selected displaced femoral-neck fractures, and post-traumatic joint destruction when cemented fixation is selected. They are handled by orthopedic arthroplasty surgeons in hospital operating rooms, specialist joint-replacement centers, trauma departments, and tertiary orthopedic facilities using compatible femoral preparation, trialing, head assembly, and stem-insertion instrumentation.

Collarless Dual-Tapered Stem Mechanics

The Gen X stem combines a collarless proximal body, dual longitudinal taper, rectangular cross-section, polished surface, modular head junction, and narrowed distal tip. Tapering in two planes produces a wedge-shaped profile that interacts with the cured cement mantle during axial loading. Rather than depending on a collar resting against the medial calcar, the force-closed design permits limited controlled subsidence within polymethylmethacrylate while generating radial compression. The rectangular section maintains defined anterior, posterior, medial, and lateral orientation during insertion and helps the surgeon control version within the prepared canal. Its polished exterior reduces mechanical interlocking between the metal and cement, allowing the loaded-taper mechanism to operate without the biologic fixation expected from porous or hydroxyapatite-coated surfaces. The narrowed distal segment reduces unnecessary occupation of the diaphyseal canal and supports central positioning when used with the appropriate restrictor and centralization technique. A compatible femoral head is assembled onto the proximal junction only after definitive stem seating. During implantation, the surgeon controls axial depth, anteversion, coronal alignment, cement pressurization, and component stability until polymerization is complete.

Cemented Total Hip Replacement Workflow

Implantation follows femoral-head excision and neck resection through the surgeon’s selected posterior, direct lateral, anterolateral, or anterior approach. The proximal canal is opened in line with the femoral axis, then sequentially prepared with Gen X-compatible rasps to establish size, version, depth, and rotational orientation. Trial components are used to evaluate limb length, offset, soft-tissue tension, impingement, and joint stability before opening the definitive sterile package. Once the selected configuration is established, the medullary canal is irrigated, cleared of loose debris, and dried. A cement restrictor is positioned distally, and polymethylmethacrylate is introduced retrogradely before pressurization. The stem is advanced into the cement bed at the planned anteversion while alignment is maintained and excess material is removed. Movement is avoided during polymerization because unintended rotation or axial displacement can compromise mantle integrity. After curing, the compatible head is assembled, the hip is reduced, and stability is assessed through the intended range of motion. In osteoporotic or compromised femoral bone, cemented fixation provides an alternative when biologic ingrowth or reliable press-fit engagement is unsuitable for the operative plan.

Selection of Gen X Stem Dimensions

Model 174X-135-S measures 135 mm in length and 10 mm in width, forming the smallest option for a comparatively narrow prepared femoral canal. Model 174X-140-M combines a 140 mm body with an 11 mm width and provides an intermediate profile for canal morphology between the listed small and large configurations. Model 174X-145-L measures 145 mm by 12 mm and occupies the broadest prepared space within this range. Selection begins with calibrated anteroposterior and lateral radiographs that assess canal width, proximal femoral geometry, neck resection level, offset, and planned center of rotation. Final sizing depends on sequential rasp progression, axial depth, trial reduction, version, and the ability to preserve a uniform cement envelope. The widest component must not be selected merely to achieve cortical contact because this system is intended for cemented fixation. An undersized prosthesis can create excessive space, asymmetric positioning, or an unsuitable mantle, while an oversized option can restrict cement thickness and increase insertion difficulty. The definitive model should correspond with the trial preparation and the compatible head configuration needed to restore hip mechanics without altering the intended stem position.

Implant Material, Sterile Handling, and Compliance

Medical-grade stainless steel supplies the rigidity, fatigue resistance, corrosion resistance, and machinability required for a load-bearing femoral component. Its highly polished exterior supports the force-closed cemented mechanism and distinguishes the implant from roughened stems intended for osseointegration. The product is supplied sterile for a single implantation procedure and is not a reusable surgical instrument. Operating-room personnel should inspect the external carton, sterile barrier, model code, dimensions, lot number, and expiration date before presentation to the sterile field. Packaging that is opened, punctured, wet, expired, or otherwise compromised must not be used. CE documentation relates to conformity assessment under the applicable European medical-device framework, while ISO 13485 addresses the manufacturer’s medical-device quality management system. FDA procurement requires the establishment, listing, labeling, importer, and market-access records applicable to the supplied device and destination. These terms should not be presented as interchangeable regulatory approvals. Hospitals and distributors should retain purchasing, receiving, lot-traceability, implantation, and complaint-handling records. The polished implant must not be cleaned, resterilized, returned to inventory after opening, or transferred for use in another patient.

How does the dual-tapered Gen X stem differ from a Müller-design femoral stem?
Modular Stems Dual Tapered Gen X Series uses a collarless, double-tapered body intended to settle incrementally within a cement mantle. A traditional Müller-design stem commonly incorporates a proximal collar that rests near the calcar. The Gen X profile converts axial loading into radial cement compression without relying on collar support. Its polished rectangular geometry also differs from porous-coated stems intended for direct bone ingrowth. Both designs require controlled canal preparation, trialing, cement delivery, alignment, and polymerization. Selection depends on the approved implant system, femoral morphology, fixation strategy, and the arthroplasty surgeon’s operative assessment.

How are the 135 mm, 140 mm, and 145 mm models selected?
Modular Stems Dual Tapered Gen X Series should be templated on calibrated anteroposterior and lateral hip radiographs. The 135 × 10 mm model addresses the narrowest prepared canal within the available range. The 140 × 11 mm configuration provides the intermediate dimensional option. The 145 × 12 mm version suits the broadest canal preparation supported by this series. Intraoperative selection must account for rasp progression, femoral version, axial depth, cement-mantle thickness, offset, limb length, and trial stability. The final implant code should match the completed trial preparation rather than dimensions selected solely from the radiograph.

What do CE, ISO 13485, and FDA references mean for procurement?
CE documentation concerns conformity with the applicable European medical-device requirements for the supplied product. ISO 13485 relates to the quality management system governing medical-device manufacturing and traceability. These designations do not independently mean that a device has received FDA approval. United States procurement requires the applicable establishment, listing, labeling, importer, and distribution documentation. Modular Stems Dual Tapered Gen X Series should arrive with identifiable model, lot, sterile-status, and expiry information. Procurement teams should retain these records within supplier qualification, implant control, patient traceability, and post-market complaint procedures.

How is the modular junction handled during implantation?
The proximal junction receives a compatible femoral head after the stem has been definitively cemented and the mantle has polymerized. The interface must remain clean, dry, undamaged, and free from blood, cement, bone particles, packaging fibers, or glove contamination. Trial heads are used first to assess offset, limb length, joint stability, and impingement. The definitive head is then seated using the assembly and impaction method specified for the corresponding implant system. Modular Stems Dual Tapered Gen X Series must not be combined with unvalidated head components or taper geometries. Cross-system mixing can impair junction seating and compromise the mechanical integrity of the reconstructed hip.

How should hospitals store and manage this sterile femoral implant?
Modular Stems Dual Tapered Gen X Series should remain in its original unopened sterile packaging until the surgical team confirms the required model. Inventory personnel should protect the package from moisture, crushing, excessive heat, direct sunlight, and uncontrolled handling. Model code, dimensions, lot number, expiry date, and barrier condition should be checked during receiving and before surgery. An opened, damaged, wet, contaminated, or expired package must be segregated from usable stock. The component must not be resterilized or reassigned to another patient after its barrier has been opened. Implant code and lot information should be recorded in the operating-room register, patient record, inventory system, and institutional traceability documentation.